Complete characterization of KADCYLA using a new Orbitrap Excedion Pro BioPharma hybrid mass spectrometer with electron-transfer/higher-energy collision dissociation (EThcD) fragmentation

Posters | 2025 | Thermo Fisher Scientific | ASMSInstrumentation
LC/HRMS, LC/Orbitrap, LC/MS/MS, LC/MS, Software
Industries
Pharma & Biopharma
Manufacturer
Thermo Fisher Scientific
Downloadable PDF for viewing
 

Similar PDF

Complete characterization of a lysine-linked antibody drug conjugate by native LC/MS intact mass analysis and peptide mapping
In-depth peptide mapping of biopharmaceuticals using an electron-transfer/higher-energy collision dissociation (EThcD) implemented on a modified Orbitrap hybrid MS
Complete Characterization of Trastuzumab Deruxtecan, a Cysteine-linked antibody drug conjugate, using high resolution accurate mass (HRAM) Mass Spectrometry
Orbitrap Excedion Pro hybrid mass spectrometer
Orbitrap Excedion Pro hybrid mass spectrometer
2025|Thermo Fisher Scientific|Brochures and specifications